MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-02-2026
Quanterix Corporation Market Cap 2011-2026 | QTRX
As of March 27, 2026 Quanterix Corporation has a market cap of $ 153 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Quanterix Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 269 M | 242 M | 893 M | 483 M | 1.21 B | 2.24 B | 767 M | 463 M | 456 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.24 B | 242 M | 781 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 166.38 | -6.17 % | $ 12.5 B | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 33.72 | -4.58 % | $ 5.02 K | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.07 | -3.41 % | $ 257 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
160 M | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Abbott Laboratories
ABT
|
196 B | $ 103.99 | -0.55 % | $ 181 B | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
175 M | $ 24.55 | 0.16 % | $ 208 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 69.17 | -1.43 % | $ 102 B | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Establishment Labs Holdings
ESTA
|
2.31 B | $ 55.31 | -7.68 % | $ 1.64 B |  Costa-rica |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 34.58 | -5.7 % | $ 1.07 B | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
3.03 M | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
48.8 B | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
IRIDEX Corporation
IRIX
|
48.1 M | $ 0.99 | -26.67 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 97.36 | -1.4 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 85.33 | -1.73 % | $ 2.96 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
1.49 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
13.2 B | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 50.13 | -0.54 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | USA |